HGEN Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 янв. 2024 @ 21:45):

Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called cytokine storm'...

Stats
Объем за сегодня	2.06M
Средний объем	341 846
Рыночная капитализация	23 816.00
EPS	$-0.0348 ( Q1 \| 2023-05-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.000392 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00100 (1 000.00%)

AADI -10.43%

ABCL 2.78%

ABCM 0.04%

ABEO 1.19%

ABIO 6.39%

ABOS 2.54%

ABSI 0.98%

ABUS -0.32%

ABVX 3.69%

ACAD -0.73%

ACER -17.95%

ACET -9.70%

ACGN 1.29%

ACHL 0.62%

ACHV 1.29%

ACIU 0.50%

ACLX 1.98%

ACRV 0.69%

ACST -2.67%

ACXP -2.60%

ADAG 6.66%

ADAP -0.60%

ADGI 0.87%

ADIL 1.77%

ADMA 2.10%

ADPT 4.62%

ADTX -2.84%

ADVM -1.72%

ADXN -3.06%

AEON -0.94%

AEZS -2.64%

AFMD 0.00%

AGEN 18.63%

AGIO -1.12%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 3.11%

AKRO 0.26%

AKTX 0.75%

AKUS 0.00%

ALBO 0.00%

ALDX -2.65%

ALEC 0.00%

ALGS -7.51%

ALKS -0.78%

ALLK -5.66%

ALLO -4.51%

ALLR 3.85%

ALNA 3.16%

ALNY -1.62%

ALPN 0.02%

ALPX 0.00%

ALRN -4.48%

ALT 4.15%

ALVR -7.27%

ALXN 0.00%

ALXO 3.34%

ALZN -0.65%

AMRN -1.84%

AMTI -3.13%

ANAB 1.05%

ANEB 3.80%

ANGN 0.00%

ANIX -7.14%

ANL -6.05%

ANNX 1.66%

ANPC -3.15%

APGE -1.50%

APGN 8.48%

APGNW 30.65%

APLM 1.30%

APLS -7.61%

APLT 1.52%

APM -5.26%

APOP 0.38%

APRE -0.49%

APTO 1.20%

APTX 3.17%

APVO -40.57%

ARAV -13.39%

ARCT -0.41%

ARDS -17.87%

ARDX 14.00%

ARGX -3.35%

ARNA 0.00%

ARPO -0.90%

ARQT -1.27%

ARTL 3.08%

ARTLW 0.00%

ARVN 2.98%

ARWR 1.17%

ASLN 4.90%

ASMB -6.03%

ASND 0.72%

ATAI 0.76%

ATHA 0.38%

ATHE 0.56%

ATHX -33.50%

ATNF 9.27%

ATOS 4.39%

ATRA 2.91%

ATXI -2.23%

ATXS -1.30%

AUPH 1.60%

AURA 3.85%

AUTL 4.50%

AVBP 6.61%

AVEO 0.00%

AVIR -2.07%

AVRO -1.41%

AVTE -0.60%

AVTX -5.53%

AVXL -1.63%

AXLA 0.00%

AXSM 0.51%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.52%

BCAB -6.80%

BCDA -0.34%

BCDAW 0.00%

BCEL 0.00%

BCLI -6.08%

BCRX 1.15%

BCTX 9.62%

BCTXW 1.47%

BCYC -0.15%

BDRX 2.98%

BDTX -0.85%

BEAM -2.29%

BFRA -2.91%

BGNE -2.00%

BIOR 2.37%

BIVI -10.22%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -1.37%

BLTE -1.76%

BLU 0.03%

BLUE 3.74%

BMEA -0.66%

BMRN -1.40%

BNOX 3.51%

BNTC -0.71%

BNTX -0.02%

BOLD -14.76%

BOLT 0.32%

BPMC -0.68%

BPTH 2.56%

BPTS -13.47%

BRNS 1.45%

BRTX 10.93%

BTAI 0.79%

BTTX 30.91%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -2.44%

CABA 1.91%

CADL 5.26%

CALA 0.00%

CALC 25.71%

CALT 0.72%

CAPR 2.80%

CARA -15.27%

CARM 18.75%

CASI 12.24%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 3.79%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO 0.37%

CDIOW 21.56%

CDMO 1.85%

CDMOP 0.04%

CDT 3.92%

CDTTW -12.92%

CDTX 6.70%

CDXC 3.02%

CDXS 2.99%

CELC 0.68%

CELU 11.79%

CELUW 0.00%

CERC -1.68%

CERE 0.96%

CERO -1.77%

CEROW 43.57%

CFRX -27.95%

CGEM 2.05%

CGEN -4.55%

CGON 4.36%

CGTX -0.60%

CHMA -6.00%

CHRS 1.76%

CINC 0.00%

CING -45.21%

CINGW 4.85%

CKPT 4.37%

CLBS -16.75%

CLDX -1.80%

CLGN -0.60%

CLLS 0.54%

CLNN -3.47%

CLNNW 3.32%

CLRB 7.30%

CLSD 1.56%

CLSN -0.68%

CLVS 0.00%

CMMB -4.26%

CMND 25.37%

CMPI 0.00%

CMPX -16.67%

CMRA 0.00%

CMRAW 33.33%

CMRX -1.47%

CNCE 0.00%

CNSP -4.82%

CNST 0.00%

CNTA 0.56%

CNTB 18.75%

CNTX -0.25%

COCP -8.63%

COEPW 0.00%

COGT -0.12%

CORT 1.34%

COYA -0.49%

CPRX 2.99%

CRBP 3.12%

CRBU -2.38%

CRDF -4.72%

CRGX 4.99%

CRIS -7.38%

CRNX 3.04%

CRSP -2.47%

CRTX 2.63%

CRVO -0.29%

CRVS -2.67%

CSBR 0.39%

CTCX 9.02%

CTIC 0.06%

CTMX -3.17%

CTNM -6.08%

CTXR -8.54%

CUE -11.43%

CVAC 1.19%

CVKD 1.82%

CWBR 0.00%

CYAD -12.96%

CYCC -4.71%

CYCCP -11.68%

CYCN 5.99%

CYT -2.27%

CYTK 0.74%

CYTO 0.00%

DARE -8.79%

DAWN -0.36%

DBTX -0.81%

DBVT -5.53%

DFFN 10.28%

DICE 0.06%

DMAC -3.28%

DNLI 1.09%

DNTH 3.85%

DOMH -1.58%

DRMA 4.37%

DRMAW 7.69%

DRNA 0.00%

DRTS 23.41%

DRTSW -8.84%

DRUG 2.32%

DSGN 0.00%

DTIL 3.29%

DYAI -6.33%

EARS -1.77%

EDIT -1.48%

EDSA -2.51%

EFTR -6.42%

EFTRW 0.00%

EIGR -9.21%

ELAB -1.48%

ELDN 1.54%

ELEV 7.57%

ELOX 12.20%

ELTX -40.35%

ELVN -0.34%

ELYM -5.58%

ENGN 5.13%

ENGNW -0.83%

ENLV -4.70%

ENOB 1.79%

ENSC -2.78%

ENTA 2.37%

ENTO 2.51%

ENTX -5.64%

ENVB 0.71%

EPIX 1.54%

EPRX 0.78%

EPZM 0.00%

EQ 3.77%

EQRX -2.09%

EQRXW 0.00%

ERAS 2.16%

ERNA 5.17%

ERYP 1.30%

ESLA 12.90%

ESLAW 0.00%

ETNB 6.23%

ETON -0.90%

ETTX 0.00%

EVAX 1.05%

EVGN -5.74%

EVLO -99.83%

EWTX 2.91%

EXAI -2.30%

EXEL -0.27%

EYEG -0.50%

EYEN -14.16%

EYPT -0.57%

FATE 0.46%

FBIO 1.79%

FBIOP 1.02%

FBLG 7.08%

FBRX -2.01%

FDMT 0.29%

FENC -0.65%

FGEN -13.37%

FHTX 0.17%

FIXX 0.77%

FMTX 0.00%

FNCH 13.22%

FOLD 0.10%

FREQ 4.76%

FRLN 0.15%

FRTX 5.56%

FSTX 0.00%

FTRE 2.01%

FULC -1.27%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 2.73%

GANX 2.40%

GBIO -1.05%

GBT 0.01%

GDTC 5.05%

GERN -4.50%

GHRS -2.75%

GLMD 2.46%

GLPG -1.43%

GLSI 2.25%

GLTO -5.16%

GLUE 10.65%

GLYC -11.22%

GMAB -1.76%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -6.48%

GNLX -11.36%

GNPX -3.33%

GNTA -0.32%

GOSS -5.38%

GOVX -10.28%

GOVXW -20.59%

GPCR 0.33%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -12.42%

GRTX 1.33%

GTHX 1.33%

GUTS -3.61%

GXGXW 41.67%

GYRE 20.63%

HALO 1.41%

HARP 0.09%

HCWB 1.06%

HEPA -5.55%

HGEN -84.62%

HILS 5.66%

HLVX 8.15%

HOOK -8.97%

HOTH -0.79%

HOWL -2.79%

HRMY -4.16%

HRTX 2.64%

HSTO 0.00%

HUMA 2.13%

HUMAW -1.42%

IBRX -3.36%

ICCC 11.24%

ICPT 0.21%

ICU 10.16%

ICUCW 12.50%

ICVX -0.91%

IDRA -23.04%

IDYA 2.15%

IFRX 4.19%

IGMS 3.93%

IKNA -5.71%

IKT -12.32%

IMAB -1.18%

IMCR 0.33%

IMGN 0.02%

IMGO 0.00%

IMMP 7.49%

IMMX -7.04%

IMNM 1.09%

IMNN 0.87%

IMPL -27.27%

IMRA 15.96%

IMRN -3.97%

IMRX -10.49%

IMTX -1.44%

IMTXW 2.21%

IMUX 8.82%

IMV 0.00%

IMVT 1.54%

INAB -5.87%

INBX 0.78%

INCY -1.19%

INDP -7.02%

INFI -52.38%

INKT 2.06%

INM 0.19%

INMB 1.50%

INO 4.12%

INSM 0.07%

INTS 0.20%

INVA 1.23%

INZY -1.33%

IOBT -0.85%

IONS 0.91%

IOVA 0.12%

IPA 1.23%

IPHA -1.52%

IPSC 0.79%

IRON 1.62%

ISEE 0.38%

ITOS -4.26%

ITRM -4.58%

IVA -0.33%

IVVD -8.33%

JAGX -1.11%

JANX 3.84%

JAZZ -0.35%

JNCE 0.00%

JSPR 3.13%

JSPRW 5.15%

JUNS 0.00%

JUNSW 0.00%

KA -5.43%

KALV -2.24%

KDNY 0.22%

KMPH -0.34%

KNSA 0.43%

KNTE -0.38%

KOD -3.29%

KPRX 1.20%

KPTI -10.84%

KRBP 6.83%

KRON 3.33%

KROS 1.40%

KRRO 1.20%

KRTX 0.03%

KRYS 0.42%

KTRA -3.60%

KTTA 1.62%

KTTAW 0.92%

KURA 0.44%

KYMR -1.22%

KYTX 1.90%

KZIA 2.65%

KZR -5.41%

LABP 0.57%

LBPH 20.19%

LBPS 0.00%

LBPSW 14.81%

LEGN -0.83%

LENZ -2.92%

LEXX 5.70%

LEXXW -5.15%

LGND 2.34%

LGNDV 0.00%

LGVN -4.17%

LIAN -8.28%

LIFE 2.70%

LIPO -3.43%

LIXT -2.47%

LIXTW -3.71%

LJPC -0.32%

LMNL 0.12%

LOGC -2.06%

LPCN 6.32%

LPTX 10.73%

LQDA -3.07%

LRMR -1.36%

LSTA -0.57%

LTRN 2.86%

LUMO 2.20%

LVTX -3.74%

LXEO 7.94%

LXRX -3.45%

LYEL 5.07%

LYRA 5.93%

MACK 0.10%

MBIO 1.59%

MBRX -3.83%

MCRB -7.80%

MDGL -1.93%

MDNA -13.16%

MDWD 4.30%

MDXG 2.51%

MEIP -1.36%

MESO -0.58%

MGNX 3.16%

MGTA -7.74%

MGTX -0.47%

MGX 8.22%

MIRM 3.26%

MIRO 0.59%

MIST 2.33%

MITO 0.00%

MLEC 1.85%

MLECW -28.57%

MLND -5.36%

MLTX 5.47%

MLYS 1.74%

MNKD -1.32%

MNMD -0.55%

MNOV 0.00%

MNPR -1.67%

MOLN 4.33%

MOR 0.17%

MORF 0.18%

MREO 3.45%

MRKR 12.42%

MRNA -2.01%

MRNS -4.88%

MRSN 0.75%

MRTX -0.17%

MRUS -1.71%

MRVI 1.13%

MTCR -1.29%

MTEM 3.60%

MTP -18.50%

MURA 2.28%

MYMD -1.08%

NAMS -1.69%

NAMSW -3.11%

NAUT 2.63%

NBRV 0.71%

NBSE -1.56%

NBTX -10.71%

NCNA -4.49%

NERV 4.59%

NEXI 0.00%

NGM -1.28%

NGNE 4.51%

NKGN 2.42%

NKGNW -12.00%

NKTR 8.77%

NKTX 0.85%

NLSP -9.63%

NLSPW 7.48%

NMRA 6.85%

NMTR -42.97%

NOVN -24.84%

NRBO 0.83%

NRIX 0.63%

NRSN 9.80%

NRSNW 21.18%

NRXP -6.87%

NRXPW -16.53%

NRXS 4.51%

NTBL -6.32%

NTEC -12.45%

NTHI 0.00%

NTLA -3.49%

NTRBW 74.65%

NUVL -1.44%

NVAX -1.33%

NVCT 0.96%

NVIV -34.28%

NXTC -3.05%

NYMX -0.05%

OABI -0.53%

OABIW 6.37%

OBIO 2.77%

OBSV 0.00%

OCEA -11.59%

OCGN 8.39%

OCS 1.44%

OCUL 1.18%

OCUP 0.66%

ODT -4.27%

OKYO 0.85%

OLMA -3.48%

OMER 2.78%

OMGA -7.59%

ONCO -18.40%

ONCR -3.08%

ONCS 31.87%

ONCT -1.17%

ONCY -1.98%

ONTX -0.47%

ONVO -0.41%

OPNT 0.00%

OPT 3.21%

ORGS -5.36%

ORIC 2.32%

ORMP -4.10%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.73%

OVID 5.89%

OYST 0.00%

PALI -1.53%

PASG -14.04%

PBLA 11.11%

PBM -8.81%

PBYI 0.93%

PCSA 8.21%

PCVX -4.14%

PDSB -2.66%

PEPG -3.04%

PGEN 4.64%

PHAR 3.47%

PHAS 0.00%

PHAT -0.96%

PHIO 1.75%

PHIOW 36.47%

PHVS 4.39%

PHXM -5.20%

PIRS 5.83%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 0.84%

PLUR 7.04%

PMN -1.96%

PMVP -2.41%

PNT 0.16%

PPBT -6.42%

PRAX 4.02%

PRDS 0.93%

PRLD 3.25%

PROG -3.47%

PROK 1.65%

PRQR 0.61%

PRTA 0.54%

PRTC 4.56%

PRTG -6.11%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -1.34%

PSTX 7.35%

PTCT -11.77%

PTE -0.82%

PTGX 8.69%

PTIXW -47.77%

PULM 0.52%

PXMD -9.45%

PYPD 3.12%

PYXS 3.12%

QLGN -3.31%

QNCX 4.87%

QNRX -2.85%

QSI 11.70%

QSIAW 4.08%

QTTB 17.70%

QURE -1.32%

RAIN -1.63%

RANI -3.55%

RAPT 5.54%

RARE -0.77%

RCKT 0.47%

REGN 0.02%

RENB 16.67%

REPL 5.63%

RETA 0.02%

REUN -0.89%

REVB 2.69%

REVBU 3.46%

REVBW 19.05%

RGLS -11.85%

RGNX 0.60%

RIGL -13.75%

RLAY 3.49%

RLMD 0.33%

RLYB -9.46%

RNA 0.76%

RNAC -5.29%

RNAZ -0.50%

RNXT -2.59%

ROIV 0.00%

ROIVW 4.56%

RPHM -6.21%

RPRX -1.12%

RPTX -2.37%

RUBY 2.70%

RVLP -32.05%

RVMD 0.73%

RVMDW 45.86%

RVNC -0.39%

RVPH 0.00%

RVPHW 1.89%

RXDX 0.09%

RXRX -0.99%

RYTM 2.32%

RYZB 0.02%

RZLT 7.23%

SABS 6.16%

SABSW 35.43%

SAGE 1.59%

SANA 1.11%

SAVA -34.83%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -2.80%

SCPH -0.46%

SCPS 0.00%

SEEL -2.10%

SEER -4.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -10.11%

SGMT -16.79%

SGTX -2.56%

SIOX 22.63%

SLDB -1.22%

SLGL 3.37%

SLN 0.00%

SLNO -2.28%

SLRX -2.86%

SLS 4.39%

SMMT -0.89%

SNDX 1.03%

SNGX -7.19%

SNPX 0.99%

SONN -1.41%

SPPI -0.49%

SPRB -2.72%

SPRC -5.99%

SPRO -2.99%

SRNE 5.26%

SRPT 0.03%

SRRA 0.00%

SRRK -0.36%

SRZN 10.16%

STAB 0.00%

STOK 1.50%

STRO 0.34%

STSA 0.00%

STTK 2.93%

SURF -0.93%

SVRA 5.77%

SWTX 0.37%

SYBX -1.96%

SYRS -9.95%

TALS -0.73%

TARA -4.15%

TARS 7.99%

TBPH 1.80%

TCBP -1.31%

TCDA 0.00%

TCON -1.38%

TCRR 0.00%

TCRT -2.92%

TCRX -6.25%

TECH -0.24%

TENX 1.17%

TERN -4.22%

TFFP 3.11%

TGTX -0.89%

THRX 0.12%

TIL -1.06%

TLC 0.00%

TLSA 4.43%

TNGX 0.47%

TNXP 1.07%

TNYA 5.44%

TPST 0.92%

TRDA 0.56%

TRVI 1.36%

TRVN 1.40%

TSHA 3.46%

TSVT 2.39%

TTNP 0.91%

TVTX -0.72%

TYRA 3.50%

UBX -2.17%

UNCY 23.70%

URGN -1.12%

UTHR 0.51%

VACC 11.36%

VALN -5.14%

VAXX -0.24%

VBIV 1.54%

VBLT -8.77%

VCEL -2.20%

VCNX 2.69%

VCYT -1.46%

VERA 4.39%

VERU 5.16%

VERV 2.52%

VIGL -10.71%

VINC 9.46%

VIR 0.34%

VIRI -8.20%

VIRX -5.93%

VKTX 4.41%

VLON -13.04%

VNDA -2.75%

VOR -12.28%

VRCA 0.97%

VRDN 1.80%

VRNA -6.35%

VRPX -0.52%

VRTX -0.80%

VSTM 2.76%

VTGN 0.00%

VTVT -0.34%

VTYX -3.35%

VXRT 0.20%

VYGR 0.64%

VYNE 0.00%

VYNT 7.78%

WINT -3.60%

WVE 0.00%

XBIO 1.50%

XBIT 11.50%

XCUR 5.89%

XENE 4.22%

XERS -0.44%

XFOR -13.45%

XLO 0.80%

XLRN 0.00%

XNCR -1.41%

XOMA 3.45%

XOMAO 0.24%

XOMAP 0.08%

XRTX 0.00%

YMAB -2.03%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.08%

ZNTL -2.62%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-10-18	Chappell Dale	Sell	276 210	Common Stock, $0.001 par value
2023-10-18	Chappell Dale	Sell	75 887	Common Stock, $0.001 par value
2023-10-18	Chappell Dale	Sell	34 253	Common Stock, $0.001 par value
2022-07-27	Buxton Cheryl	Buy	78 362	Stock Option (Right to Buy)
2022-07-27	Hohneker John	Buy	63 195	Stock Option (Right to Buy)

INSIDER POWER
3.43
Last 98 transactions
Buy: 5 830 886 \| Sell: 2 957 610

Объем Корреляция

Длинно: 0.10 (neutral)

Кратко: 0.00 (neutral)

Signal:(38.548) Neutral

Humanigen, Inc. Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Humanigen, Inc. Корреляция - Валюта/Сырье

0.87
( strong )

-0.18
( neutral )

0.00
( neutral )

-0.73
( moderate negative )

Humanigen, Inc. Финансовые показатели

Annual	2022
Выручка:	$2.51M
Валовая прибыль:	$2.51M (100.00 %)
EPS:	$-1.180

FY	2022
Выручка:	$2.51M
Валовая прибыль:	$2.51M (100.00 %)
EPS:	$-1.180

FY	2021
Выручка:	$3.60M
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$-3.98

FY	2020
Выручка:	$312 000
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$-2.42

Financial Reports:

No articles found.

Humanigen, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Humanigen, Inc.

Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with COVID-19 for which it has completed a Phase 3 study and is the focus of a Phase 2/3 study sponsored by the NIH. It is also developing lenzilumab, which is also being studied in conjunction with CD19-targeted CAR-T cell therapies, as well as exploring the effectiveness of lenzilumab in other inflammatory conditions, such as acute Graft versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplantation and in eosinophilic asthma, and rheumatoid arthritis. In addition, the company focuses on studying lenzilumab for patients with chronic myelomonocytic leukemia exhibiting RAS pathway mutations. Its pipeline also includes two other Humaneered monoclonal antibodies, ifabotuzumab, which binds to EphA3, and HGEN005, which targets EMR1. Ifabotuzumab has been evaluated in a Phase 1 study of glioblastoma multiforme that showed tumor specific targeting of all known tumor sites with no normal tissue uptake. HGEN005 is being explored as a treatment for a range of eosinophilic diseases, including eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct. Humanigen, Inc. was incorporated in 2000 and is headquartered in Short Hills, New Jersey.